Featured Research

from universities, journals, and other organizations

Modified Botox: Taking The Wrinkles Out Of Motoneuronal Disease

Date:
July 10, 2006
Source:
University Of Queensland
Summary:
A winner of UniQuest's 2006 Trailblazer innovation competition, Dr. Frederic Meunier, is developing a treatment for motoneuronal diseases based on modifying botox -- the popular anti-wrinkle treatment.

A winner of UniQuest's 2006 Trailblazer innovation competition, Dr Frederic Meunier is developing a treatment for motoneuronal diseases based on modifying botox – the popular anti-wrinkle treatment.

Motoneuronal diseases cause a degeneration of the nerve pathways controlling muscle activity. The diseases are severe and physically debilitating disorders which lead to progressive weakness and wasting of muscles. Many of the diseases are incurable.

Dr Meunier is developing botox to selectively deliver drugs to motoneurons to directly treat motorneuron diseases.

“I first became interested in investigating neurotoxins because they are fantastic molecular tools to dissect synaptic mechanisms,” Dr Meunier said.

“The aim of our lab is to understand the molecular mechanism underlying neuronal communication. The legacy of millions of years of evolution and competition between venomous species has resulted in deadly neurotoxins capable of blocking neuronal communication. I am using our knowledge of the mode of action of these neurotoxins to design a selective motoneuron delivery system that could change our way of treating motoneuronal diseases.”

Dr Meunier's innovative research caught the attention of UQ's main commercialisation company, UniQuest Pty Ltd, which runs the annual Trailblazer competition.

UniQuest Managing Director David Henderson said the Trailblazer judges were impressed by Dr Meunier's research and the opportunities surrounding it.

“The therapeutic applications of this research are important, as it could help prevent or cure motoneuronal diseases,” Mr Henderson said.

“Also, the research potentially has important applications for the treatment of other diseases.”

Trailblazer is an annual event designed to reward and inspire researchers as well as promote innovative research with commercial potential. In 2006, entries were received from across all UQ's faculties with 11 awards presented to staff and students.


Story Source:

The above story is based on materials provided by University Of Queensland. Note: Materials may be edited for content and length.


Cite This Page:

University Of Queensland. "Modified Botox: Taking The Wrinkles Out Of Motoneuronal Disease." ScienceDaily. ScienceDaily, 10 July 2006. <www.sciencedaily.com/releases/2006/07/060710084936.htm>.
University Of Queensland. (2006, July 10). Modified Botox: Taking The Wrinkles Out Of Motoneuronal Disease. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2006/07/060710084936.htm
University Of Queensland. "Modified Botox: Taking The Wrinkles Out Of Motoneuronal Disease." ScienceDaily. www.sciencedaily.com/releases/2006/07/060710084936.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins